Abstract
The AKT-mTOR signaling transduction pathway plays an important role in neurodevelopment and synaptic plasticity. mTOR is a serine/threonine kinase that modulates signals from multiple neurotransmitters and phosphorylates specific proteins to regulate protein synthesis and cytoskeletal organization. There is substantial evidence demonstrating abnormalities in AKT expression and activity in different schizophrenia (SZ) models. However, direct evidence for dysregulated mTOR kinase activity and its consequences on downstream effector proteins in SZ pathophysiology is lacking. Recently, we reported reduced phosphorylation of mTOR at an activating site and abnormal mTOR complex formation in the SZ dorsolateral prefrontal cortex (DLPFC). Here, we expand on our hypothesis of disrupted mTOR signaling in the SZ brain and studied the expression and activity of downstream effector proteins of mTOR complexes and the kinase activity profiles of SZ subjects. We found that S6RP phosphorylation, downstream of mTOR complex I, is reduced, whereas PKCĪ± phosphorylation, downstream of mTOR complex II, is increased in SZ DLPFC. In rats chronically treated with haloperidol, we showed that S6RP phosphorylation is increased in the rat frontal cortex, suggesting a potential novel mechanism of action for antipsychotics. We also demonstrated key differences in kinase signaling networks between SZ and comparison subjects for both males and females using kinome peptide arrays. We further investigated the role of mTOR kinase activity by inhibiting it with rapamycin in postmortem tissue and compared the impact of mTOR inhibition in SZ and comparison subjects using kinome arrays. We found that SZ subjects are globally more sensitive to rapamycin treatment and AMP-activated protein kinase (AMPK) contributes to this differential kinase activity. Together, our findings provide new insights into the role of mTOR as a master regulator of kinase activity in SZ and suggest potential targets for therapeutic intervention.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86ā97.
Funk AJ, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH. Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia. Neuropsychopharmacology. 2012;37:896ā905.
Kyosseva SV, Elbein AD, Griffin WST, Mrak RE, Lyon M, Karson CN. Mitogen-activated protein kinases in schizophrenia. Biol. Psychiatry. 1999;46:689ā96.
Emamian ES. AKT/GSK3 signaling pathway and schizophrenia. Front. Mol. Neurosci. 2012;5:33.
Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3Ī² signaling in schizophrenia. Nat. Genet. 2004;36:131ā7.
McGuire JL, Hammond JH, Yates SD, Chen D, Haroutunian V, Meador-Woodruff JH, et al. Altered serine/threonine kinase activity in schizophrenia. Brain Res. 2014;1568:42ā54.
Chadha, R & Meador-Woodruff, JH Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia. Neuropsychopharmacology 1ā9 (2020) https://doi.org/10.1038/s41386-020-0614-2.
Wang L, Zhou K, Fu Z, Yu D, Huang H, Zang X, et al. Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases. J. Mol. Neurosci. 2017;61:379ā84.
Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 2013;16:1537ā43.
McGuire JL, Depasquale EA, Funk AJ, OāDonnovan SM, Hasselfeld K, Marwaha S, et al. Abnormalities of signal transduction networks in chronic schizophrenia. NPJ Schizophr. 2017;3:30.
Bentea E, Depasquale EAKK, Oādonovan SM, Sullivan CR, Simmons M, Meador-Woodruff JH, et al. Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia. Mol. Omi. 2019;15:173ā88.
Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman JE, Belmaker RH, Agam G. Reduced GSK-3Ī² mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J. Neural Transm. 2004;111:1583ā92.
Gong R, Park CS, Abbassi NR, Tang S-J. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 2006;281:18802ā15.
Hsu W-L, Chung H-W, Wu C-Y, Wu H-I, Lee Y-T, Chen E-C, et al. Glutamate Stimulates Local Protein Synthesis in the Axons of Rat Cortical Neurons by Activating Ī±-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors and Metabotropic Glutamate Receptors. J. Biol. Chem. 2015;290:20748ā60.
English J, Fan Y, Fƶcking M, Lopez L, Hryniewiecka M, Wynne K, et al. Reduced protein synthesis in schizophrenia patient-derived olfactory cells. Transl. Psychiatry. 2015;5:e663.
Huang W, Zhu PJ, Zhang S, Zhou H, Stoica L, Galiano M, et al. mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 2013;16:441ā8.
Ibarra-Lecue I, Diez-Alarcia R, Morentin B, Meana JJ, Callado LF, UrigĆ¼en L. Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia. Front. Pharmacol. 2020;11:344.
Kim P, Scott MR, Meador-Woodruff JH. Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2018;197:484ā91.
Kippe JM, Mueller TM, Haroutunian V, Meador-Woodruff JH. Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophr. Res. 2015;166:219ā24.
Bauer DE, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. Expression of four housekeeping proteins in elderly patients with schizophrenia. J. Neural Transm. 2009;116:487ā91.
Harte MK, Bachus SB, Reynolds GP. Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol. Schizophr. Res. 2005;75:303ā8.
Kashihara K, Sato M, Fujiwara Y, Harada T, Ogawa T, Otsuki S. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Biol. Psychiatry. 1986;21:650ā6.
Bhambhvani HP, Mueller TM, Simmons MS, Meador-Woodruff JH. Actin polymerization is reduced in the anterior cingulate cortex of elderly patients with schizophrenia. Transl. Psychiatry. 2017;7:1278.
Dorsett CR, McGuire JL, Niedzielko TL, Depasquale EAK, Meller J, Floyd CL, et al. Traumatic brain injury induces alterations in cortical glutamate uptake without a reduction in glutamate transporter-1 protein expression. J. Neurotrauma. 2017;34:220ā34.
DePasquale EAK, Alganem K, Bentea E, Nawreen N, McGuire JL, Naji F, et al. KRSA: Network-based Prediction of Differential Kinase Activity from Kinome Array Data. bioRxiv. 2020. https://doi.org/10.1101/2020.08.26.268581. 2020.08.26.268581
Xue Y, Liu Z, Gao X, Jin C, Wen L, Yao X, et al. GPS-SNO: Computational Prediction of Protein S-Nitrosylation Sites with a Modified GPS Algorithm. PLoS One. 2010;5:e11290.
Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45:D362āD368.
Biever A, Valjent E, Puighermanal E. Ribosomal protein S6 phosphorylation in the nervous system: From regulation to function. Front. Mol. Neurosci. 2015;8:75.
Hetman M, Slomnicki LP. Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies. J. Neurochem. 2019;148:325ā47.
Slomnicki LP, Pietrzak M, Vashishta A, Jones J, Lynch N, Elliot S, et al. Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree. J. Biol. Chem. 2016;291:5721ā39.
Bowling H, Zhang G, Bhattacharya A, PĆ©rez-Cuesta LM, Deinhardt K, Hoeffer CA, et al. Antipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexity. Sci. Signal. 2014;7:ra4.
Valjent E, Bertran-Gonzalez J, Bowling H, Lopez S, Santini E, Matamales M, et al. Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32. Neuropsychopharmacology. 2011;36:2561ā70.
Bonito-Oliva A, Pallottino S, Bertran-Gonzalez J, Girault J-A, Valjent E, Fisone G. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. Neuropharmacology. 2013;72:197ā203.
Pan B, Huang XF, Deng C. Aripiprazole and haloperidol activate GSK3Ī²-dependent signalling pathway differentially in various brain regions of rats. Int. J. Mol. Sci. 2016;17:459.
Roh M-S, Seo MS, Kim Y, Kim SH, Jeon WJ, Ahn YM, et al. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp. Mol. Med. 2007;39:353ā60.
Garza-LombĆ³ C, Schroder A, Reyes-Reyes EM, Franco R. mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival. Current Opinion in Toxicology. 2018;8:102ā10.
Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint. Mol. Cell. 2008;30:214ā26.
Inoki K, Kim J, Guan K-L. AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets. Annu. Rev. Pharmacol. Toxicol. 2012;52:381ā400.
Rabanal-Ruiz Y, Otten EG, Korolchuk VI. MTORC1 as the main gateway to autophagy. Essays in Biochemistry. 2017;61:565ā84.
Al Eissa MM, Fiorentino A, Sharp SI, OāBrien NL, Wolfe K, Giaroli G, et al. Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia. Ann. Hum. Genet. 2018;82:88ā92.
Barnes MR, Huxley-Jones J, Maycox PR, Lennon M, Thornber A, Kelly F, et al. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J. Neurosci. Res. 2011;89:1218ā27.
Kroemer G, MariƱo G, Levine B. Autophagy and the Integrated Stress Response. Molecular Cell. 2010;40:280ā93.
Horesh Y, Katsel P, Haroutunian V, Domany E. Gene expression signature is shared by patients with Alzheimerās disease and schizophrenia at the superior temporal gyrus. Eur. J. Neurol. 2011;18:410ā24.
Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry. 2000;57:65ā73.
Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience. 2013;251:90ā107.
Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry. 1998;65:446ā53.
Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends in Neurosciences. 2012;35:57ā67.
Rojas-BenĆtez D, Ibar C, Glavic Ć. The Drosophila EKC/KEOPS complex: Roles in protein synthesis homeostasis and animal growth. Fly (Austin). 2013;7:168ā72.
Wu MF, Wang SG. Human TAO kinase 1 induces apoptosis in SH-SY5Y cells. Cell Biol. Int. 2008;32:151ā6.
Pinner AL, Tucholski J, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2016;177:78ā87.
Mccullumsmith RE, Hammond JH, Shan D, Meador-Woodruff JH. Postmortem brain: An underutilized substrate for studying severe mental illness. Neuropsychopharmacology. 2014;39:65ā87.
Acknowledgements
The authors would like to thank Dr. Rosalinda Roberts and the Alabama Brain Collection for postmortem cortical samples used in assay development for immunoblotting analyses.
Funding
RC was supported by the Marie and Emmett Carmichael fund for graduate students in biosciences. KA and REM were supported by NIMH R01 MH107487 and MH121102.
Author information
Authors and Affiliations
Contributions
Authors RC and JMW designed the study. RC executed experimental protocols, performed data calculations, statistical analyses, and literature searches. RC performed the biochemical studies, whereas kinome array experiments were executed and analyzed by KA. RC wrote the first draft of the manuscript, followed by editing by JMW and REM. All authors contributed to and have approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Chadha, R., Alganem, K., Mccullumsmith, R.E. et al. mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain. Mol Psychiatry 26, 6868ā6879 (2021). https://doi.org/10.1038/s41380-021-01135-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-021-01135-9
This article is cited by
-
Psychedelics and schizophrenia: a double-edged sword
Molecular Psychiatry (2024)
-
Analysis of single-cell transcriptome data from a mouse model implicates protein synthesis dysfunction in schizophrenia
Genes & Genomics (2024)
-
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes
Molecular Psychiatry (2023)
-
Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
Translational Psychiatry (2022)
-
A Learning Based Framework for Disease Prediction from Images of Human-Derived Pluripotent Stem Cells of Schizophrenia Patients
Neuroinformatics (2022)